Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1949217

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1949217

Global Oral Rehydration Solution (ORS) Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The Oral Rehydration Solution (ORS) Market size is expected to reach USD 8.48 Billion in 2034 from USD 3.61 Billion (2025) growing at a CAGR of 9.97% during 2026-2034.

The Oral Rehydration Solution (ORS) Market is poised for significant growth as the demand for effective rehydration therapies increases, particularly in regions with high incidences of dehydration due to diarrhea and other gastrointestinal disorders. ORS is a simple and cost-effective solution that helps replenish lost fluids and electrolytes, making it a critical component of public health initiatives. The rising awareness of the importance of hydration and the effectiveness of ORS in preventing severe dehydration is driving the demand for these solutions globally.

Technological advancements are playing a crucial role in shaping the future of the ORS market. Innovations in formulation science, including the development of flavored and ready-to-use ORS products, are enhancing the acceptability and ease of use for patients, particularly children. Additionally, advancements in packaging and distribution methods are improving access to ORS in underserved areas. As manufacturers continue to invest in research and development, the ORS market is likely to see increased adoption across various healthcare settings, including hospitals, clinics, and community health programs.

Moreover, the growing emphasis on preventive healthcare and education is influencing the ORS market's growth trajectory. As healthcare providers and organizations focus on promoting awareness of dehydration and the benefits of ORS, there is a rising demand for educational resources and community outreach programs. This trend is driving collaboration between manufacturers, healthcare professionals, and public health agencies to develop initiatives that empower individuals and families to manage hydration effectively. As the market continues to evolve, the integration of technology, education, and community engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Tablets
  • Powders
  • Solutions

By Application

  • Hospitals
  • Clinics
  • Home Care
  • Others

By Distribution Channel

  • Online Stores
  • Pharmacies
  • Supermarkets/Hypermarkets
  • Specialty Stores
  • Others

By End-User

  • Infants
  • Children
  • Adults
  • Elderly

COMPANIES PROFILED

  • Johnson Johnson, Sanofi, Pfizer Inc, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Novartis AG, Merck Co, Inc, F HoffmannLa Roche Ltd, Cipla Limited, Sun Pharmaceutical Industries Ltd, Daiichi Sankyo Company, Limited, Reckitt Benckiser Group plc, Nestl SA, Baxter International Inc

We can customise the report as per your requriements

Product Code: VMR11219611

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Powders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Distribution Channel
  • 6.2. Online Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Supermarkets/Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Infants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Elderly Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Application
    • 8.2.3 By Distribution Channel
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Application
    • 8.3.3 By Distribution Channel
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Application
    • 8.4.3 By Distribution Channel
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Application
    • 8.5.3 By Distribution Channel
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Application
    • 8.6.3 By Distribution Channel
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson & Johnson
    • 10.2.2 Sanofi
    • 10.2.3 Pfizer Inc
    • 10.2.4 Abbott Laboratories
    • 10.2.5 GlaxoSmithKline Plc
    • 10.2.6 Bayer AG
    • 10.2.7 Novartis AG
    • 10.2.8 Merck & Co.Inc
    • 10.2.9 F. Hoffmann-La Roche Ltd
    • 10.2.10 Cipla Limited
    • 10.2.11 Sun Pharmaceutical Industries Ltd
    • 10.2.12 Daiichi Sankyo Company, Limited
    • 10.2.13 Reckitt Benckiser Group Plc
    • 10.2.14 NestlAfA(C) S.A
    • 10.2.15 Baxter International Inc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!